Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Optimizing therapy for patients with brain metastases

Optimizing therapy for patients with brain metastases SEMINARS IN ONCOLOGY Kuo, T., Recht, L. 2006; 33 (3): 299-306

Abstract

Brain metastases from systemic cancers are the most common malignant brain tumors encountered. Although prognosis remains poor, it is possible to stratify patients according to risk. Furthermore, an aggressive therapeutic approach for good-risk patients that includes a combination of either surgery or stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) can improve survival and decrease the risk of central nervous system progression.

View details for DOI 10.1053/j.seminoncol.2006.03.005

View details for Web of Science ID 000238731100003

View details for PubMedID 16769418